nach oben

Erschienen in:

15.04.2019 | Research Article

Comparison of [¹⁸F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: a Pilot Study

verfasst von: Aliaksandra Shymanskaya, Wieland A. Worthoff, Gabriele Stoffels, Johannes Lindemeyer, Bernd Neumaier, Philipp Lohmann, Norbert Galldiks, Karl-Josef Langen, N. Jon Shah

Erschienen in: Molecular Imaging and Biology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Positron emission tomography (PET) using O-(2-[¹⁸F]fluoroethyl)-L-tyrosine ([¹⁸F]FET) improves the diagnostics of cerebral gliomas compared with conventional magnetic resonance imaging (MRI). Sodium MRI is an evolving method to assess tumor metabolism. In this pilot study, we explored the relationship of [¹⁸F]FET-PET and sodium MRI in patients with cerebral gliomas in relation to the mutational status of the enzyme isocitrate dehydrogenase (IDH).

Procedures

Ten patients with untreated cerebral gliomas and one patient with a recurrent glioblastoma (GBM) were investigated by dynamic [¹⁸F]FET-PET and sodium MRI using an enhanced simultaneous single-quantum- and triple-quantum-filtered imaging of ²³Na (SISTINA) sequence to estimate total (NaT), weighted non-restricted (NaNR, mainly extracellular), and restricted (NaR, mainly intracellular) sodium in tumors and normal brain tissue. [¹⁸F]FET uptake and sodium parameters in tumors with a different IDH mutational status were compared. After biopsy or resection, histology and the IDH mutational status were determined neuropathologically.

Results

NaT (p = 0.05), tumor-to-brain ratios (TBR) of NaT (p = 0.02), NaNR (p = 0.003), and the ratio of NaT/NaR (p < 0.001) were significantly higher in IDH-mutated than in IDH-wild-type gliomas (n = 5 patients each) while NaR was significantly lower in IDH-mutated gliomas (p = 0.01). [¹⁸F]FET parameters (TBR, time-to-peak) were not predictive of IDH status in this small cohort of patients. There was no obvious relationship between sodium distribution and [¹⁸F]FET uptake. The patient with a recurrent GBM exhibited an additional radiation injury with strong abnormalities in sodium MRI.

Conclusions

Sodium MRI appears to be more strongly related to the IDH mutational status than are [¹⁸F]FET-PET parameters. A further evaluation of the combination of the two methods in a larger group of high- and low-grade gliomas seems promising.

Nur mit Berechtigung zugänglich

Ostrom QT, Gittleman H, Liao P et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 16(Suppl 4):iv1–i63CrossRefPubMedPubMedCentral

Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479–489CrossRefPubMed

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820CrossRefPubMed

Langen KJ, Galldiks N, Hattingen E, Shah NJ (2017) Advances in neuro-oncology imaging. Nat Rev Neurol 13:279–289CrossRefPubMed

Leu K, Ott GA, Lai A, Nghiemphu PL, Pope WB, Yong WH, Liau LM, Cloughesy TF, Ellingson BM (2017) Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas. J Neuro-Oncol 134:177–188CrossRef

Xing Z, Yang X, She D, Lin Y, Zhang Y, Cao D (2017) Noninvasive assessment of IDH mutational status in World Health Organization grade II and III astrocytomas using DWI and DSC-PWI combined with conventional MR imaging. AJNR Am J Neuroradiol 38:1138–1144CrossRefPubMedPubMedCentral

Kunz M, Albert NL, Unterrainer M et al (2018) Dynamic ¹⁸F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas. Neuro-Oncology

Suchorska B, Giese A, Biczok A, Unterrainer M, Weller M, Drexler M, Bartenstein P, Schüller U, Tonn JC, Albert NL (2018) Identification of time-to-peak on dynamic ¹⁸F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro-Oncology 20:279–288CrossRefPubMed

Verger A, Stoffels G, Bauer EK, Lohmann P, Blau T, Fink GR, Neumaier B, Shah NJ, Langen KJ, Galldiks N (2018) Static and dynamic ¹⁸F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status. Eur J Nucl Med Mol Imaging 45:443–451CrossRefPubMed

10.

Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL (2018) Biological tumour volumes of gliomas in early and standard 20-40 min ¹⁸F-FET PET images differ according to IDH mutation status. Eur J Nucl Med Mol Imaging 45:1242–1249CrossRefPubMed

11.

Rohrich M, Huang K, Schrimpf D et al (2018) Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas. Eur J Nucl Med Mol Imaging 45:1573–1584CrossRefPubMed

12.

Lopci E, Riva M, Olivari L, Raneri F, Soffietti R, Piccardo A, Bizzi A, Navarria P, Ascolese AM, Rudà R, Fernandes B, Pessina F, Grimaldi M, Simonelli M, Rossi M, Alfieri T, Zucali PA, Scorsetti M, Bello L, Chiti A (2017) Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. Eur J Nucl Med Mol Imaging 44:1155–1164CrossRefPubMed

13.

Madelin G, Regatte RR (2013) Biomedical applications of sodium MRI in vivo. J Magn Reson Imaging 38:511–529CrossRefPubMedPubMedCentral

14.

Shah NJ, Worthoff WA, Langen KJ (2016) Imaging of sodium in the brain: a brief review. NMR Biomed 29:162–174CrossRefPubMed

15.

Murphy E, Eisner DA (2009) Regulation of intracellular and mitochondrial sodium in health and disease. Circ Res 104:292–303CrossRefPubMedPubMedCentral

16.

Thulborn KR, Lu A, Atkinson IC, Damen F, Villano JL (2009) Quantitative sodium MR imaging and sodium bioscales for the management of brain tumors. Neuroimaging Clin N Am 19:615–624CrossRefPubMedPubMedCentral

17.

Ouwerkerk R, Bleich KB, Gillen JS, Pomper MG, Bottomley PA (2003) Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 227:529–537CrossRefPubMed

18.

Nagel AM, Bock M, Hartmann C, Gerigk L, Neumann JO, Weber MA, Bendszus M, Radbruch A, Wick W, Schlemmer HP, Semmler W, Biller A (2011) The potential of relaxation-weighted sodium magnetic resonance imaging as demonstrated on brain tumors. Investig Radiol 46:539–547CrossRef

19.

Fiege DP, Romanzetti S, Mirkes CC, Brenner D, Shah NJ (2013) Simultaneous single-quantum and triple-quantum-filtered MRI of ²³Na (SISTINA). Magn Reson Med 69:1691–1696CrossRefPubMed

20.

Worthoff WA, Shymanskaya A, Shah NJ (2019) Relaxometry and quantification in simultaneously acquired single and triple quantum filtered sodium MRI. Magn Reson Med 81:303–315CrossRefPubMed

21.

Jaccard G, Wimperis S, Bodenhausen G (1986) Multiple-quantum Nmr-spectroscopy of S=3/2 spins in isotropic-phase - a new probe for multiexponential relaxation. J Chem Phys 85:6282–6293CrossRef

22.

Keltner JR, Wong ST, Roos MS (1994) Three-dimensional triple-quantum-filtered imaging of 0.012 and 0.024 M sodium-23 using short repetition times. J Magn Reson B 104:219–229CrossRefPubMed

23.

Woessner DE (2001) NMR relaxation of spin-(3)/(2) nuclei: effects of structure, order, and dynamics in aqueous heterogeneous systems. Concept Magn Res 13:294–325CrossRef

24.

Babsky AM, Zhang H, Hekmatyar SK, Hutchins GD, Bansal N (2007) Monitoring chemotherapeutic response in RIF-1 tumors by single-quantum and triple-quantum-filtered ²³Na MRI, (1)H diffusion-weighted MRI and PET imaging. Magn Reson Imaging 25:1015–1023CrossRefPubMed

25.

Biller A, Badde S, Nagel A, Neumann JO, Wick W, Hertenstein A, Bendszus M, Sahm F, Benkhedah N, Kleesiek J (2016) Improved brain tumor classification by sodium MR imaging: prediction of IDH mutation status and tumor progression. AJNR Am J Neuroradiol 37:66–73CrossRefPubMedPubMedCentral

26.

Hamacher K, Coenen HH (2002) Efficient routine production of the 18F-labelled amino acid O-2-¹⁸F fluoroethyl-L-tyrosine. Appl Radiat Isot 57:853–856CrossRefPubMed

27.

Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, Stöcklin G (1999) Synthesis and radiopharmacology of O-(2-[¹⁸F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 40:205–212PubMed

28.

Langen KJ, Bartenstein P, Boecker H, Brust P, Coenen HH, Drzezga A, Grünwald F, Krause BJ, Kuwert T, Sabri O, Tatsch K, Weber WA, Schreckenberger M (2011) German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids. Nuklearmedizin 50:167–173CrossRefPubMed

29.

Herzog H, Tellmann L, Hocke C, Pietrzyk U, Casey ME, Kuwert T (2004) NEMA NU2-2001 guided performance evaluation of four siemens ECAT PET scanners. IEEE Trans Nucl Sci 51:2662–2669CrossRef

30.

Unterrainer M, Vettermann F, Brendel M, Holzgreve A, Lifschitz M, Zähringer M, Suchorska B, Wenter V, Illigens BM, Bartenstein P, Albert NL (2017) Towards standardization of ¹⁸F-FET PET imaging: do we need a consistent method of background activity assessment? EJNMMI Res 7:48CrossRefPubMedPubMedCentral

31.

Pauleit D, Floeth F, Hamacher K et al (2005) O-(2-[¹⁸F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128:678–687CrossRefPubMed

32.

Fiege DP, Romanzetti S, Tse DH et al (2013) B0 insensitive multiple-quantum resolved sodium imaging using a phase-rotation scheme. J Magn Reson 228:32–36CrossRefPubMed

33.

Worthoff WA, Shymanskaya A, Shah NJ (2018) Relaxometry and quantification in simultaneously acquired single and triple quantum filtered sodium MRI. Magn Reson Med Sci in press

34.

Woolrich MW, Jbabdi S, Patenaude B, Chappell M, Makni S, Behrens T, Beckmann C, Jenkinson M, Smith SM (2009) Bayesian analysis of neuroimaging data in FSL. Neuroimage 45:S173–S186CrossRefPubMed

35.

Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, de Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, de Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1):S208–S219CrossRefPubMed

36.

Jenkinson M, Beckmann CF, Behrens TE et al (2012) Fsl. Neuroimage 62:782–790CrossRefPubMed

37.

Kaufman PL, Adler FH, Levin LA, Alm A (2011) Adler’s physiology of the eye. Elsevier Health Sci

38.

Coe JI (1969) Postmortem chemistries on human vitreous humor. Am J Clin Pathol 51:741–750CrossRefPubMed

39.

Ouwerkerk R, Bleich KB, Gillen JS, Pomper MG, Bottomley PA (2003) Tissue sodium concentration in human brain tumors as measured with Na-23 MR imaging. Radiology 227:529–537CrossRefPubMed

40.

Nunes Neto LP, Madelin G, Sood TP, Wu CC, Kondziolka D, Placantonakis D, Golfinos JG, Chi A, Jain R (2018) Quantitative sodium imaging and gliomas: a feasibility study. Neuroradiology 60:795–802CrossRefPubMedPubMedCentral

41.

Joshi AD, Parsons DW, Velculescu VE, Riggins GJ (2011) Sodium ion channel mutations in glioblastoma patients correlate with shorter survival. Mol Cancer 10:17CrossRefPubMedPubMedCentral

42.

Wang R, Gurguis CI, Gu W, Ko EA, Lim I, Bang H, Zhou T, Ko JH (2015) Ion channel gene expression predicts survival in glioma patients. Sci Rep 5:11593CrossRefPubMedPubMedCentral

43.

Cong D, Zhu W, Shi Y, Pointer KB, Clark PA, Shen H, Kuo JS, Hu S, Sun D (2014) Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H(+) extrusion, cell migration and survival. Carcinogenesis 35:2014–2024CrossRefPubMedPubMedCentral

44.

Zhu W, Carney KE, Pigott VM, Falgoust LM, Clark PA, Kuo JS, Sun D (2016) Glioma-mediated microglial activation promotes glioma proliferation and migration: roles of Na+/H+ exchanger isoform 1. Carcinogenesis 37:839–851CrossRefPubMedPubMedCentral

45.

Cameron IL, Smith NK, Pool TB, Sparks RL (1980) Intracellular concentration of sodium and other elements as related to mitogenesis and oncogenesis in vivo. Cancer Res 40:1493–1500PubMed

46.

Romanzetti S, Mirkes CC, Fiege DP, Celik A, Felder J, Shah NJ (2014) Mapping tissue sodium concentration in the human brain: a comparison of MR sequences at 9.4 Tesla. Neuroimage 96:44–53CrossRefPubMed

47.

Shah NJ (2015) Multimodal neuroimaging in humans at 9.4 T: a technological breakthrough towards an advanced metabolic imaging scanner. Brain Struct Funct 220:1867–1884CrossRefPubMed

48.

Shah NJ, Oros-Peusquens AM, Arrubla J, Zhang K, Warbrick T, Mauler J, Vahedipour K, Romanzetti S, Felder J, Celik A, Rota-Kops E, Iida H, Langen KJ, Herzog H, Neuner I (2013) Advances in multimodal neuroimaging: hybrid MR-PET and MR-PET-EEG at 3 T and 9.4 T. J Magn Reson 229:101–115CrossRefPubMed

Titel: Comparison of [18F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: a Pilot Study
verfasst von: Aliaksandra Shymanskaya
Wieland A. Worthoff
Gabriele Stoffels
Johannes Lindemeyer
Bernd Neumaier
Philipp Lohmann
Norbert Galldiks
Karl-Josef Langen
N. Jon Shah
Publikationsdatum: 15.04.2019
Verlag: Springer International Publishing
Erschienen in: Molecular Imaging and Biology / Ausgabe 1/2020
Print ISSN: 1536-1632
Elektronische ISSN: 1860-2002
DOI: https://doi.org/10.1007/s11307-019-01349-y

Neu im Fachgebiet Radiologie

08.04.2024 | Andrologie | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Comparison of [¹⁸F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: a Pilot Study

Abstract

Purpose

Procedures

Results

Conclusions

Neu im Fachgebiet Radiologie

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Die Ganz-Genom-Sequenzierung startet

Update Radiologie

Springer Medizin

Abstract

Purpose

Procedures

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Target-Specific Imaging of Cathepsin and S100A8/A9 Reflects Specific Features of Malignancy and Enables Estimation of Tumor Malignancy

Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14–16, 2018; Vienna, Austria

Molecular Imaging of a Zirconium-89 Labeled Antibody Targeting Plasmodium falciparum–Infected Human Erythrocytes

Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer

Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake

Letter to the Editor re: “Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake”

Neu im Fachgebiet Radiologie

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Die Ganz-Genom-Sequenzierung startet

Update Radiologie